BÜNYAMİN KAPLAN

Prof. Bünyamin Kaplan is a radiation oncologist with a medical degree from Erciyes University Faculty of Medicine (1996). He brings decades of clinical experience in radiation oncology and has been affiliated with Acibadem Health Group since 2021. An active member of the professional community, he holds memberships in the Turkish Oncology Society, Radiation Oncology Society, the Turkish Cancer Research and Fighting Organization, and the Association for Experimental and Clinical Research. His work focuses on delivering advanced, evidence-based radiation treatments and contributing to cancer research and clinical practice improvements.

Education

• 1996 Erciyes University Faculty of Medicine Radiation Oncology
• 1995 Istanbul University Oncology Institute / Brachytherapy/3-D Computerized Planning Rotation
• 1993 Istanbul University Oncology Institute / Medical Oncology Rotation
• 1990 Erciyes University Faculty of Medicine

Experience

• 2021 Acibadem Health Group
• 2019 Erciyes University Faculty of Medicine / Prof.Dr.
• 2017 – 2019 Medipol Mega Hospital, Istanbul / Prof.Dr.
• 2010 – 2017 Acibadem Kayseri Hospital (part-time) / Prof.Dr.
• 2010 – 2017 Erciyes University Faculty of Medicine / Prof.Dr.
• 2009 – 2010 Acibadem Kayseri Hospital (part-time) / Assoc.Dr.
• 2004 – 2009 Erciyes University Faculty of Medicine / Assoc.Dr.
• 2000 – 2009 Erciyes University Faculty of Medicine / Assoc. Prof. Dr.
• 2000 – 2001 MD Anderson Cancer Center, Houston, Texas, USA / Visiting Scientist
• 1996 – 1999 Erciyes University Faculty of Medicine / Uz.Öğ.Gör.
• 1992 – 1996 Erciyes University Faculty of Medicine / Dr.Ar.Assist.

Memberships

• Turkish Oncology Society
• Radiation Oncology Society
• Turkish Cancer Research and Fighting Organization
• Association for Experimental and Clinical Research

Publications

• Is human kallikrein-11 in non-small cell lung cancer treated chemoradiotherapy associated with survival?
  Cancer Res Treat. 2016;48(1):98-105. doi: 10.4143/crt.2014.364 D. Unal, C. Eroglu, A. Tasdemir, H. Karaman, N. Kurtul, B. Kaplan.
• Effect of radiotherapy dose rates on early intestinal toxicity.
  Turk J Oncol 2016;31(1):5-9. doi: 10.5505/tjo.2016.1399 . D. Ünal, S. Aydoğan, A. Taşdemir, T.D. Ünal, H. Çelik, H. Karaman, C. Eroğlu, B. Kaplan.
• Effect of radiotherapy on psychiatric disorder in patients with head and neck cancer
  Indian J Cancer. 2016;53(1):162-165. doi: 10.4103/0019-509X.180816 D. Unal, O. Orhan, S.D. Ozsoy, A. Besirli, C. Eroglu, B. Kaplan.
• Effect on long-term survival of psychiatric disorder, inflammation, malnutrition, and radiotherapy-related toxicity in patients with locally advanced head and neck cancer
  JBUON 2015;20(3):886-893. D. Unal, C. Eroglu C, S.D. Ozsoy, A. Besirli, O. Orhan, B. Kaplan
• Effect of prognostic factors on survival in elderly patients with non-small cell lung cancer.
  Turkish Journal of Geriatrics. 2014;17(2):113-118. D. Unal, A. Oguz, S.S. Goksu, A. Tasdemir, N. Kurtul, C. Eroglu, O. Orhan, B. Kaplan
• Prognostic value of SPARC expression in cases with unresectable NSCLC treated with concurrent chemoradiotherapy
  Asian Pac J Cancer Prev. 2014;15(20):8911-8916. doi: 10.7314/APJCP.2014.15.20.8911 N. Kurtul, C. Eroglu, D. Unal, E.A. Tasdemir, O. Orhan, G. Zararsız, M. Baran, O. Kontas, B. Kaplan.
• ABO Blood Groups are Not Associated with Treatment Response and Prognosis in Patients with Locally Advanced Non- Small Cell Lung Cancer.
  Asian Pac J Cancer Prev. 2013;14(6):3945-8. doi: 10.7314/APJCP.2013.14.6.3945 D. Unal, C. Eroglu, N. Kurtul, A. Oguz, A. Tasdemir, B. Kaplan.
• Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
  Ann Thorac Med. 2013;8(2):109-115. doi: 10.4103/1817-1737.109824 C. Eroglu, O. Orhan, D. Unal, G.G. Dogu, H. Karaca, M. Dikilitas, A. Ozturk, M. Ozkan, B. Kaplan.
• The effect of being overweight on survival in patients with gastric cancer undergoing adjuvant chemoradiotherapy
  Eur J Cancer Care (Engl). 2013;22(1):133-140. doi: 10.1111/ecc.12010 C. Eroglu, O. Orhan, H. Karaca, D. Unal, M. Dikilitas, M. Ozkan, B. Kaplan.
• Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer.
  Wspolczesna Onkol (Contemporary Oncology) 2013;17(3):276-280. doi: 10.5114/wo.2013.35281 D. Unal, O. Orhan, C. Eroglu, B. Kaplan.